Effect of in vivo and in vitro treatment with dialyzable leukocyte extracts on human natural killer cell activity

I. Láng, K. Nékám, Péter Gergely, Gyula Petrányi

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The effects of in vivo and in vitro treatment with human dialyzable leukocyte extracts (DLE) on natural killer (NK) cell activity were studied in 12 patients with malignancies in an allogenic test system using K-562 target cells. A marked increase in NK cell activity was observed in 7 patients with originally low cytotoxic capacity, while originally normal NK cell activity of other tumor patients and of healthy subjects was not significantly influenced by DLE treatment. The observed stimulation of NK cell activity by DLE may be a possible mechanism of its therapeutic effects.

Original languageEnglish
Pages (from-to)139-144
Number of pages6
JournalClinical Immunology and Immunopathology
Volume25
Issue number1
DOIs
Publication statusPublished - 1982

Fingerprint

Transfer Factor
Natural Killer Cells
Therapeutic Uses
Therapeutics
Neoplasms
Healthy Volunteers
In Vitro Techniques

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Pathology and Forensic Medicine

Cite this

Effect of in vivo and in vitro treatment with dialyzable leukocyte extracts on human natural killer cell activity. / Láng, I.; Nékám, K.; Gergely, Péter; Petrányi, Gyula.

In: Clinical Immunology and Immunopathology, Vol. 25, No. 1, 1982, p. 139-144.

Research output: Contribution to journalArticle

@article{15de5510402a404a8d4c554cbd9d9914,
title = "Effect of in vivo and in vitro treatment with dialyzable leukocyte extracts on human natural killer cell activity",
abstract = "The effects of in vivo and in vitro treatment with human dialyzable leukocyte extracts (DLE) on natural killer (NK) cell activity were studied in 12 patients with malignancies in an allogenic test system using K-562 target cells. A marked increase in NK cell activity was observed in 7 patients with originally low cytotoxic capacity, while originally normal NK cell activity of other tumor patients and of healthy subjects was not significantly influenced by DLE treatment. The observed stimulation of NK cell activity by DLE may be a possible mechanism of its therapeutic effects.",
author = "I. L{\'a}ng and K. N{\'e}k{\'a}m and P{\'e}ter Gergely and Gyula Petr{\'a}nyi",
year = "1982",
doi = "10.1016/0090-1229(82)90173-8",
language = "English",
volume = "25",
pages = "139--144",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Effect of in vivo and in vitro treatment with dialyzable leukocyte extracts on human natural killer cell activity

AU - Láng, I.

AU - Nékám, K.

AU - Gergely, Péter

AU - Petrányi, Gyula

PY - 1982

Y1 - 1982

N2 - The effects of in vivo and in vitro treatment with human dialyzable leukocyte extracts (DLE) on natural killer (NK) cell activity were studied in 12 patients with malignancies in an allogenic test system using K-562 target cells. A marked increase in NK cell activity was observed in 7 patients with originally low cytotoxic capacity, while originally normal NK cell activity of other tumor patients and of healthy subjects was not significantly influenced by DLE treatment. The observed stimulation of NK cell activity by DLE may be a possible mechanism of its therapeutic effects.

AB - The effects of in vivo and in vitro treatment with human dialyzable leukocyte extracts (DLE) on natural killer (NK) cell activity were studied in 12 patients with malignancies in an allogenic test system using K-562 target cells. A marked increase in NK cell activity was observed in 7 patients with originally low cytotoxic capacity, while originally normal NK cell activity of other tumor patients and of healthy subjects was not significantly influenced by DLE treatment. The observed stimulation of NK cell activity by DLE may be a possible mechanism of its therapeutic effects.

UR - http://www.scopus.com/inward/record.url?scp=0019898721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019898721&partnerID=8YFLogxK

U2 - 10.1016/0090-1229(82)90173-8

DO - 10.1016/0090-1229(82)90173-8

M3 - Article

C2 - 7151336

AN - SCOPUS:0019898721

VL - 25

SP - 139

EP - 144

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 1

ER -